胺碘酮对急性心肌梗死并发室性心动过速的治疗分析  

Clinical analysis on intravenous Amiodarone for continuous ventricular tachycardia in patients with acute myocardial infarction

作　　者：阎晋华[1] 齐守罡[1] 

机构地区：[1]大同市第三人民医院,山西大同037008

出　　处：《基层医学论坛》2012年第32期4225-4226,共2页The Medical Forum

摘　　要：目的观察静脉注射胺碘酮治疗急性心肌梗死并发室性心动过速的疗效。方法将30例急性心肌梗死患者分为2组,每组15例,分别给予静脉注射利多卡因、胺碘酮治疗,观察2组临床疗效。结果胺碘酮组15例患者中,13例患者室性心动过速得到控制,对照组有8例患者室性心动过速得到控制,胺碘酮组有效率高于对照组。结论静脉注射胺碘酮治疗急性心肌梗死并发室性心动过速安全有效,可提高急性心肌梗死的抢救成功率。Objective To investigate the effect of amiodarone to continuous ventricular tachycardia in patients with acute myocardial infarction.Methods 30 cases of acute myocardial infarction patients were divided into 2 groups,15 cases in each group,were given intravenous lidocaine,amiodarone treatment,observation of clinical curative effect of 2 sets.Results Among 15 cases in the observation group,13 patients with ventricular tachycardia were under control,in the control group,8 patients with ventricular tachycardia got controlled heartbeat,amiodarone group was higher than that of control group.Conclusion Intravenous amiodarone is more effective and safer than lidocaine in treating continuous ventricular tachycardia in patients with AMI.

关 键 词：急性心肌梗死 室性心动过速 胺碘酮 利多卡因 

分 类 号：R541.7[医药卫生—心血管疾病]